OPR - Delayed Quote • USD MRUS Dec 2024 50.000 call (MRUS241220C00050000) Follow 9.70 0.00 (0.00%) At close: April 3 at 12:49 PM EDT Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for MRUS241220C00050000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: MRUS Merus (MRUS) Moves 7.1% Higher: Will This Strength Last? Will Merus N.V. (MRUS) Report Negative Q1 Earnings? What You Should Know Merus Announces Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting Merus Presents Preclinical Data Demonstrating Efficacy of Zeno in Cancer Models with High NRG1 Expression at the AACR Annual Meeting 2024 Merus to Participate in a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference YmAbs Therapeutics (YMAB) Surges 8.2%: Is This an Indication of Further Gains? Gilead and Merus Announce Collaboration to Discover Novel Antibody-Based Trispecific T-Cell Engagers Gilead bets on ‘trispecifics’ in latest cancer drug deal Merus Announces Publication of an Abstract for Presentation at the AACR Annual Meeting 2024: Zeno is effective in cancer models with high NRG1 expression Merus Full Year 2023 Earnings: Misses Expectations Merus to Participate in a Fireside Chat at the Leerink Partners Global Biopharma Conference Earnings Update: Merus N.V. (NASDAQ:MRUS) Just Reported And Analysts Are Trimming Their Forecasts
